This platform was created after a personal diagnosis revealed how fragmented and inaccessible clinical trial information really is.
Tools and information for everyone navigating cancer — from diagnosis guides to the latest research.
A plain-language guide to gliomas, treatments, and what to expect.
Read the Glioma GuideCurated trials, molecular data, and research trends.
Browse PublicationsExplore active trials by condition, location, and treatment type.
Search TrialsWe monitor over 2,500 global medical sources 24/7, analyze new studies as they emerge, and organize everything by clinical significance. Complex research is translated into plain language, so patients and caregivers can find what matters most — without the noise.
We continuously scan ClinicalTrials.gov, PubMed, FDA, and 2,500+ medical sources for new glioma-relevant research.
Every study is classified by WHO 2021 taxonomy, scored for relevance, and enriched with molecular markers and treatment data.
Browse an intelligence dashboard, explore active clinical trials, or read a curated newsletter — all in plain language.
Behind this platform is a personal diagnosis, a frustration, and a decision. The information was scattered, the resources out of reach. We deserved more — so we built Zyntha.
Unlike traditional clinical trial databases:
Every study, trial, and article is summarized so that patients and families can actually understand it — no medical degree required.
We run 24/7, scanning 2,500+ sources. New trials and publications appear here within hours — not weeks or months.
Built specifically for the glioma community. Every feature — from molecular markers to subtype filters — speaks your language.
All content comes from peer-reviewed medical journals, verified trial registries, and top cancer research centers.
Every article is scored for glioma relevance, classified by the WHO 2021 taxonomy, and summarized in patient-friendly language before it reaches you.